Portolan Capital Management - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
Portolan Capital Management ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2020$2,405,000
-22.6%
164,717
-24.8%
0.22%
-37.8%
Q3 2020$3,109,000
-78.7%
218,924
-77.9%
0.35%
-78.9%
Q2 2020$14,585,000
+296.3%
991,497
+11.0%
1.67%
+201.8%
Q1 2020$3,680,000893,0900.55%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders